Today: 25 April 2026
Browse Category

Stock Market 14 December 2025

Oklo Inc. Stock (NYSE: OKLO) News, Forecasts and Analyst Outlook on Dec. 14, 2025 — ATM Offering, Sector Selloff, and What Investors Are Watching

Oklo Inc. Stock (NYSE: OKLO) News, Forecasts and Analyst Outlook on Dec. 14, 2025 — ATM Offering, Sector Selloff, and What Investors Are Watching

Oklo Inc. shares closed at $87.42 on Dec. 12, down 15.13% after a weeklong slide tied to weakness in uranium and nuclear-related stocks and reports of delayed data center projects. The company’s $1.5 billion at-the-market equity program, disclosed Dec. 4, remains a key concern for investors, raising dilution risk as Oklo seeks capital to fund reactor development.
14 December 2025
Modine Manufacturing Company (MOD) Stock Today: What’s Driving the Sell-Off, Fresh Analyst Targets, and 2026 Outlook (Dec. 14, 2025)

Modine Manufacturing Company (MOD) Stock Today: What’s Driving the Sell-Off, Fresh Analyst Targets, and 2026 Outlook (Dec. 14, 2025)

Modine Manufacturing shares closed at $139.88 on Friday, down 15.32% after a volatile session that ended a strong 2025 rally. G2 Investment Partners increased its stake by 52.9% in Q2, while D.A. Davidson reiterated a Buy rating with a $200 target. The drop follows renewed concerns over margin pressure despite continued data center demand.
14 December 2025
Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica shares fell nearly 13% Friday, closing at $306.50 on the NYSE and C$421.77 on the TSX, after a broad tech selloff and renewed “AI bubble” concerns. New institutional filings Sunday showed both buying and trimming of positions. Management reaffirmed a $16 billion revenue target and $8.20 adjusted EPS for 2026. RBC and Goldman maintained bullish price targets at $400 and $440, respectively.
14 December 2025
Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Databricks announced in August 2025 a Series K funding round valuing the company at over $100 billion. Reuters reported on Nov. 30 that Databricks is in talks to raise $5 billion at a $134 billion valuation, though the company declined to comment. The firm recently surpassed a $4 billion revenue run-rate and reported positive free cash flow. Secondary markets list its valuation at $100 billion as of Dec. 14.
14 December 2025
SpaceX Valuation Surges to $800 Billion in Insider Share Sale—What the Latest IPO Forecasts Say for 2026 (Updated Dec. 14, 2025)

SpaceX Valuation Surges to $800 Billion in Insider Share Sale—What the Latest IPO Forecasts Say for 2026 (Updated Dec. 14, 2025)

SpaceX set its valuation at about $800 billion after approving a secondary share sale at $421 per share, according to a Dec. 12 letter from CFO Bret Johnsen reviewed by Reuters. The deal allows up to $2.56 billion in shares to be sold to investors and SpaceX itself. The company is preparing for a possible IPO in 2026 but has not set a final timeline or valuation.
14 December 2025
RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH shares rose 5.7% Friday to $162.01 after reporting Q3 revenue of $884 million and net income of $36 million, both up 9% year over year. The company’s updated outlook cited ongoing margin pressure from tariffs and international expansion, leading several analysts to cut price targets. RH guided Q4 revenue growth of 7%–8% and an adjusted operating margin of 12.5%–13.5%. Wall Street consensus remains neutral.
Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics shares closed at $10.55 Friday, up 6.6% after hitting a 52-week high of $10.85. Renewed bullish analyst coverage, including a Zacks “strong buy” and a mean price target of $15.90, followed the move. The company’s profitability trajectory and recent earnings have drawn increased attention from investors.
lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

Lululemon shares jumped 9.6% to $204.97 on Dec. 12 after the company announced CEO Calvin McDonald will step down at the end of January 2026. The leadership change came alongside a Q3 earnings beat, raised 2025 guidance, and a $1 billion buyback increase. LULU is set to exit the Nasdaq-100 index. The stock is down nearly 48% year-to-date.
Rivian Stock (RIVN) News, Forecasts and Analysis on Dec. 14, 2025: Autonomy & AI Day, Analyst Upgrades, and What Investors Should Watch Next

Rivian Stock (RIVN) News, Forecasts and Analysis on Dec. 14, 2025: Autonomy & AI Day, Analyst Upgrades, and What Investors Should Watch Next

Rivian shares closed Friday, Dec. 12 at $18.42, up about 12% after unveiling its first custom self-driving chip and a new Autonomy+ subscription package. The company is shifting away from Nvidia processors, using chips produced by TSMC. An over-the-air update will expand hands-free driving coverage to 3.5 million miles of U.S. roads. The stock rebounded sharply after initial losses on the autonomy news.
Clear Secure (YOU) Stock News on Dec. 14, 2025: CMS Medicare.gov Deal, JPMorgan Upgrade, Insider-Sale Filing, and Updated Price Targets

Clear Secure (YOU) Stock News on Dec. 14, 2025: CMS Medicare.gov Deal, JPMorgan Upgrade, Insider-Sale Filing, and Updated Price Targets

Clear Secure shares closed at $41.08 on Friday, hitting a four-year high after surging in the mid-teens percentage range. The rally followed news of a contract with the Centers for Medicare & Medicaid Services to provide digital identity verification for Medicare.gov, set to launch in early 2026. JPMorgan also upgraded the stock.
14 December 2025
Polestar Stock (PSNY) News on Dec. 14, 2025: Reverse Split Aftermath, Nasdaq Compliance Push, and the Latest Forecasts

Polestar Stock (PSNY) News on Dec. 14, 2025: Reverse Split Aftermath, Nasdaq Compliance Push, and the Latest Forecasts

Polestar’s U.S.-listed shares underwent a 1-for-30 ADS ratio change effective Dec. 9, sending PSNY stock to around $14.33 by Friday amid high volatility. The move, aimed at regaining Nasdaq compliance, did not alter the company’s fundamentals. Polestar reported $2.17 billion in revenue and a $1.56 billion net loss for the first nine months of 2025. Tariffs and U.S. policy uncertainty continue to cloud forecasts.
14 December 2025
Greater Victoria Tourism Won’t Chase FIFA World Cup 2026 “Overflow Dollars,” Destination CEO Says — Victoria, BC News (Dec. 14, 2025)

Greater Victoria Tourism Won’t Chase FIFA World Cup 2026 “Overflow Dollars,” Destination CEO Says — Victoria, BC News (Dec. 14, 2025)

Destination Greater Victoria will not pursue FIFA World Cup 2026 “overflow dollars” from Vancouver, CEO Paul Nursey told the Times Colonist. The region’s tourism body expects little direct benefit from the event, citing geographic and logistical barriers for visitors crossing to Vancouver Island. Vancouver, meanwhile, is accelerating World Cup preparations, including a citywide fan festival and event programming.
14 December 2025
Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Pfizer shares closed at $25.85 Friday, Dec. 12, with volume near 50.8 million. The company declared a $0.43 per share dividend for Q1 2026, marking its 349th consecutive payout. New trial data showed Tukysa cut risk of progression or death in HER2+ metastatic breast cancer by about 36%. Investors remain focused on dividend sustainability and pipeline developments.
Oracle Stock (ORCL) News Today: AI Spending Shock, OpenAI Data Center Debate, and Wall Street Forecasts (Dec. 14, 2025)

Oracle Stock (ORCL) News Today: AI Spending Shock, OpenAI Data Center Debate, and Wall Street Forecasts (Dec. 14, 2025)

Oracle shares closed at $189.97 on Friday, down 4.6% after earnings missed guidance and the company announced a $15 billion increase in AI infrastructure spending for fiscal 2026. Credit default swaps on Oracle debt rose sharply. A Bloomberg report on possible OpenAI data center delays pressured the stock, though Oracle denied any impact on contracts. Wall Street price targets were cut but consensus remains a “Moderate Buy.”
Sydney attack today: Bondi Beach Hanukkah shooting leaves 12 dead, 29 injured as Australia treats incident as terrorism

Sydney attack today: Bondi Beach Hanukkah shooting leaves 12 dead, 29 injured as Australia treats incident as terrorism

A shooting at a Hanukkah event near Sydney’s Bondi Beach left 12 people dead, including one suspected gunman, and 29 injured, authorities said Sunday. Police described the attack as antisemitic terrorism. Among the dead are Rabbi Eli Schlanger and an Israeli citizen. One suspect is in custody; police are investigating reports of a possible third attacker.
14 December 2025
Broadcom Stock (AVGO) News and Forecasts on Dec. 14, 2025: AI Revenue Surge Meets Margin Pressure and “Mystery Customer” Questions

Broadcom Stock (AVGO) News and Forecasts on Dec. 14, 2025: AI Revenue Surge Meets Margin Pressure and “Mystery Customer” Questions

Broadcom shares fell 11.4% to $359.93 on Friday after management warned gross margins could dip as AI products become a larger share of revenue, despite record Q4 results and raised guidance. The selloff followed strong fiscal Q4 numbers, with revenue up 28% year-over-year to $18.02 billion, but investors focused on near-term profitability concerns.
Tesla Stock (TSLA) News on Dec. 14, 2025: Robotaxi “Three-Week” Countdown Collides With Slowing Sales—What Analysts Forecast Next

Tesla Stock (TSLA) News on Dec. 14, 2025: Robotaxi “Three-Week” Countdown Collides With Slowing Sales—What Analysts Forecast Next

Tesla’s U.S. sales dropped nearly 23% year-over-year in November to about 39,800 vehicles, the lowest since January 2022, after the federal EV tax credit ended. Despite weaker demand, Tesla shares closed at $458.96 Friday, up 2.7%. Analysts point to investor focus on robotaxi and AI ambitions as supporting the stock price. Tesla’s U.S. EV market share rose to 56.7% as overall EV sales declined.
BigBear.ai (BBAI) Stock News & Forecast: Ask Sage Deal, Share Authorization Vote, and Analyst Targets (Dec. 14, 2025)

BigBear.ai (BBAI) Stock News & Forecast: Ask Sage Deal, Share Authorization Vote, and Analyst Targets (Dec. 14, 2025)

BigBear.ai shares traded near $6 with a $2.78 billion market cap as of Dec. 14, 2025, amid high volatility. Headlands Technologies LLC raised its stake to nearly 2 million shares, making BBAI its fourth largest position. Institutional ownership stands at 7.55%. A shareholder vote on doubling authorized shares to 1 billion remains pending after adjournment.
14 December 2025

Stock Market Today

  • Fastly CEO Sells Shares Amid Strong Stock Performance; Market Impact Analyzed
    April 25, 2026, 2:48 PM EDT. Fastly CEO Charles Lacey Compton III sold 29,533 shares worth approximately $720,000 across multiple transactions on April 16-17, 2026, per SEC Form 4. This sale represents 2.54% of his direct holdings, leaving him with over 1.13 million shares valued near $27.85 million. The stock, up over 300% in a year, traded at around $24.50 during the sale, reflecting elevated price levels. Compton's sale aligns with prior patterns driven by holding reductions and tax obligations from vested RSUs. Fastly, specializing in edge cloud infrastructure with $624 million revenue trailing twelve months, maintained a market capitalization near $3.6 billion. The transaction does not indicate a strategic shift, as the CEO retains substantial equity exposure in a sector critical for digital content delivery and enterprise tech services.

Latest article

Kraft Heinz Stock Gets Fresh Dividend Cut Warning Ahead of May 6 Earnings

Kraft Heinz Stock Gets Fresh Dividend Cut Warning Ahead of May 6 Earnings

25 April 2026
BofA Securities placed Kraft Heinz in a higher-risk group for dividend cuts, and Morgan Stanley lowered its price target to $22. Shares have dropped over 40% in three years amid falling demand, cost pressures, and the impact of GLP-1 drugs. Kraft Heinz posted a $4.7 billion operating loss for 2025 and expects organic net sales to fall up to 3.5% in 2026. First-quarter results are due May 6.
Realty Income Stock Just Stumbled Before Earnings. The Dividend Test Comes Next

Realty Income Stock Just Stumbled Before Earnings. The Dividend Test Comes Next

25 April 2026
Realty Income Corp. shares dropped 1.17% to $63.33 on Friday, underperforming real estate peers ahead of its May 6 first-quarter earnings release. The company declared a $0.2705 per share monthly dividend, payable May 15. Realty Income reported 2025 AFFO of $4.28 per share and guided 2026 AFFO to $4.38–$4.42. In March, Apollo funds agreed to invest $1 billion for a 49% stake in a joint venture.
Conagra Brands Stock Faces a 9% Dividend Test After Its Slide Deepens

Conagra Brands Stock Faces a 9% Dividend Test After Its Slide Deepens

25 April 2026
Conagra Brands’ shares closed Friday at $14.17, near a 52-week low, as BofA Securities warned its dividend is among the most at risk for cuts in the packaged-food sector. The company’s board approved a 35-cent quarterly dividend payable June 3, with April 30 as the record date. Conagra’s payout ratio stands above 80%, and net sales fell 1.9% last quarter. New CEO John Brase takes over June 1.
Go toTop